Skeletal Dysplasia Account Manager - San Jose, CA
BridgeBio
September 02, 2026
Remote friendly (United States)
United States
Sales
Location: West Region (multiple territories): San Diego, Los Angeles, San Jose, Seattle, Omaha, Denver, San Francisco.
Responsibilities:
- Develop and execute a territory business plan targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and multi-disciplinary skeletal dysplasia clinic teams to meet/exceed sales goals.
- Demonstrate deep expertise in Infigratinib and achondroplasia; engage HCPs in clinically relevant, compliant discussions.
- Use sales/target data to identify growth opportunities and proactively address territory challenges; adjust priorities as needed.
- Partner compliantly with Field Medical Directors, Field Reimbursement Managers, Family Account Managers, and the HUB to maximize customer/family satisfaction.
- Build relationships with KOLs (with Marketing and Medical Affairs) to expand advocacy for Infigratinib and BridgeBio.
- Maintain selling, clinical, market, product, and territory proficiency; ensure all activities comply with regulations and Pharma guidelines.
Qualifications (required/preferred):
- 8–10 years in pharma/biotech; 4+ years in rare disease/genetic disease/skeletal dysplasia (achondroplasia or pediatric rare disease preferred).
- BS/BA required; MBA a plus.
- Willingness to travel extensively.
- Product/indication launch experience; account management success.
- Strong leadership, communication, integrity, AI fluency, and organizational skills.
Salary (California, anticipated): $155,000–$210,000 USD.
Responsibilities:
- Develop and execute a territory business plan targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and multi-disciplinary skeletal dysplasia clinic teams to meet/exceed sales goals.
- Demonstrate deep expertise in Infigratinib and achondroplasia; engage HCPs in clinically relevant, compliant discussions.
- Use sales/target data to identify growth opportunities and proactively address territory challenges; adjust priorities as needed.
- Partner compliantly with Field Medical Directors, Field Reimbursement Managers, Family Account Managers, and the HUB to maximize customer/family satisfaction.
- Build relationships with KOLs (with Marketing and Medical Affairs) to expand advocacy for Infigratinib and BridgeBio.
- Maintain selling, clinical, market, product, and territory proficiency; ensure all activities comply with regulations and Pharma guidelines.
Qualifications (required/preferred):
- 8–10 years in pharma/biotech; 4+ years in rare disease/genetic disease/skeletal dysplasia (achondroplasia or pediatric rare disease preferred).
- BS/BA required; MBA a plus.
- Willingness to travel extensively.
- Product/indication launch experience; account management success.
- Strong leadership, communication, integrity, AI fluency, and organizational skills.
Salary (California, anticipated): $155,000–$210,000 USD.